BioRestorative Therapies, Inc. (BRTX): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
BioRestorative Therapies, Inc. (BRTX) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 4.01 Changes in Registrant’s Certifying Accountant. Dismissal of CBIZ CPAs P.C. On August 28, 2026, BioRestorative Therapies, Inc. (the “ Company ”) dismissed CBIZ CPAs P.C. (“ CBIZ ”) as the Company’s independent registered public accounting firm, effective as of that date.
How this was made
The 30-second read
Why it matters
The disclosures are primary source filings, representing the first public notice of these corporate actions.
Market read
Corporate governance changes may affect stock perception; no immediate financial metrics disclosed.
What to watch
Potential impact of the auditor change on upcoming SEC filings and any pending financing activities.
Background
BioRestorative Therapies filed an 8‑K detailing executive departures, new interim CEO appointment, and a switch from CBIZ to Bush & Associates as its auditor.
Ticker impact
SEC 8‑K reports departure of interim CEO/CFO Katharyn Field and appointment of Mika Grasso as interim CEO, plus change of audit firm.
Potential modest downside as investors assess new management and audit quality.
No immediate financial impact disclosed, but executive turnover and auditor switch are material corporate actions that can affect investor confidence.
Market effects
May prompt scrutiny of governance standards in the biotech sector.
Limited to U.S. biotech investors; no broader regional effect.
Low global relevance beyond sector peers.
Counterpoint
The leadership change could be a catalyst for a short‑term rally if the new CEO is viewed as a stronger strategist.
Key entities
- personKatharyn Field
Departing interim CEO, CFO, Treasurer, and Board member.
- personMika Grasso
Appointed interim CEO and former board chair.
- companyCBIZ CPAs P.C.
Former independent auditor being replaced.
- companyBush & Associates CPA
New independent auditor effective Aug 28 2026.
